Key facts
- It has raised $26.6M across 1 recorded rounds; the latest was Early Stage VC (Series A) ($8.5M) in Mar 2023.
- Notable investors include FJ Labs, Gaingels, Calm Ventures, AlleyCorp, Union Square Ventures — 26 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Journey Clinical
Funding rounds
1 roundsAbout Journey Clinical
Developer of an online healthcare platform designed to assist psychotherapists in growing their practice with psychedelic therapy. The company provides independent licensed mental health and private psychotherapy practitioners with the prescription services they need, enabling health professionals to provide safe, effective, and transformative ketamine-assisted psychotherapy for their patients.
- Industry
- Clinics/Outpatient Services
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 45
- Website
- journeyclinical.com/
- Ownership
- Privately Held (backing)
Journey Clinical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Journey Clinical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Journey Clinical in its N-PORT filings yet. We sweep new filings monthly.